DRKS00019044已完成1 期
IGRT treatment with simultaneous integrated boost as dose escalation for patients with cervical cancer - OTI-L1
niversität von Pécs, Klinisches Zentrum, Onkotherapeutisches Institut0 个研究点目标入组 14 人开始时间: 2019年11月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- Female
入选标准
- •Stage IIb and IV Cervix cancer Patient
- •- ECOG (Eastern Cooperative Oncology Group): 1-2
- •- GFR (glomerular filtration rate): over 30 ml/min
排除标准
- •GFR: under 30 ml/min
研究者
相似试验
尚未招募
不适用
Simultaneous Integrated Boost Radiation Therapy with concomitant Capecitabine and Mitomycin-C chemotherapy for locally advanced Anal CarcinomaAnal carcinomacancer of the anus1000211210017991NL-OMON31876Antoni van Leeuwenhoek Ziekenhuis20
招募中
1 期
Modified Simultaneous Integrated Boost Radiotherapy for Large tumorJPRN-UMIN000019944Graduate School of Medical Science, Kyoto Prefectural University of Medicine15
招募中
不适用
Intensity modulated radiotherapy with IGRT for Post cricoid and upper esophageal cancer: Prospective observational studyCTRI/2017/11/010428Varian Medical Systems Inc
已完成
1 期
Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal CarcinomaEsophageal NeoplasmsNCT02429622Chinese Academy of Medical Sciences80
Unknown
3 期
The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRTNasopharyngeal CarcinomaNCT01817023Chinese Academy of Medical Sciences590